Bozonnat, A, Beylot-Barry, M, Dereure, O, D'Incan, M, Quereux, G
, Guenova, E, Perier-Muzet, M, Dalle, S, Grange, F, Viguier, M-A, Ram-Wolff, C, Feldmeyer, L, Beltraminelli, H, Bonnet, N, Amatore, F, Maubec, E, Franck, N, Machet, L, Chasset, F, Brunet-Possenti, F, Bouaziz, J-D, Battistella, M, Donzel, M, Pham-Ledard, A, Bejar, C, Moins-Teisserenc, H, Mourah, S, Saiag, P, Hainaut, E, Michel, C, Bens, G, Adamski, H, Aubin, F, Boulinguez, S, Joly, P, Tedbirt, B, Templier, I, Troin, L, Montaudié, H, Ingen-Housz-Oro, S, Faiz, S, Mortier, L, Dobos, G, Bagot, M, Resche-Rigon, M, Montlahuc, C, Serret-Larmande, A, de Masson, A & Cutaneous Lymphomas French Study Group 2025, '
Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study',
EClinicalMedicine, Jg. 79, 102979.
https://doi.org/10.1016/j.eclinm.2024.102979